Merck pulls plug on Alzheimer's drug because of li
Post# of 1460
Behind a paywall.
Quote:
Merck has ended work on two separate Phase II studies of its small molecule for treatment-resistant depression and mild-to-moderate Alzheimer’s disease, the pharma confirmed to Endpoints News.